Drug-Induced Liver Toxicity

1 Bhakuni GS, Bedi O, Bariwal J, et al. Animal models of hepatotoxicity. Inflamm Res, 2016, 65(1):13–24. https://doi.org/10.1007/s00011-015-0883-0 Search in Google Scholar

2 Andrade RJ, Robles M, Fernández-Castañer A, et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol, 2017, 13(3):329-340. https://doi.org/10.3748/wjg.v13.i3.329 Search in Google Scholar

3 Thompson WL, Takebe T. Human liver model systems in a dish. Dev Growth Differ, 2021, 63(1):47–58. https://doi.org/10.1111/dgd.12708 Search in Google Scholar

4 Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology, 2006, 43(1):54–62. https://doi.org/10.1002/hep.21060 Search in Google Scholar

5 MacParland SA, Liu JC, Ma XZ, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun, 2018, 9(1):4383. https://doi.org/10.1038/s41467-018-06318-7 Search in Google Scholar

6 Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol, 2017, 27(21):1147–1151. https://doi.org/10.1016/j.cub.2017.09.019 Search in Google Scholar

7 Simeonova R, Vitcheva V, Kondeva-Burdina M, et al. Hepato-protective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats. BioMed Res Int, 2013, 2013:757126. https://doi.org/10.1155/2013/757126 Search in Google Scholar

8 Croom E. Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci, 2012, 112:31-88. https://doi.org/10.1016/B978-0-12-415813-9.00003-9 Search in Google Scholar

9 Naik A, Beliþ A, Zanger UM, et al. Molecular interactions between NAFLD and xenobiotic metabolism. Front Genet, 2013, 4:2. https://doi.org/10.3389/fgene.2013.00002 Search in Google Scholar

10 Hodgson E, Rose RL. Metabolism of toxicants. In: A Textbook of Modern Toxicology. 4th ed. E. Hodgson (Ed.). New Jersey, John Wiley & Sons, Inc., Hoboken, 2010, 115–155. Search in Google Scholar

11 Omiecinski CJ, Vanden Heuvel JP, Perdew GH, et al. Xeno-biotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxici-ties. Toxicol Sci, 2011, 120(1):49-75. https://doi.org/10.1093/toxsci/kfq338 Search in Google Scholar

12 LeBlanc GA. Phase II—conjugation of toxicants. In: Molecular and biochemical toxicology. 4th ed. R. C. Smart, E. Hodgson (Eds.). New Jersey, John Wiley & Sons, Inc., Hoboken, 2008, 219–237. Search in Google Scholar

13 Tittarelli R, Pellegrini M, Scarpellini MG, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci, 2017, 21(1):95-101. https://www.europeanreview.org/wp/wp-content/uploads/95-101-Hepatotoxicity-of-paracetamoland-related-fatalities.pdf Search in Google Scholar

14 Leung L. From ladder to platform: a new concept for pain management. J Prim Health Care, 2012, 4:254-258. DOI:10.1071/HC12258 Search in Google Scholar

15 Massart J, Begriche K, Fromenty B. Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. Clin Res Hepatol Gastroenterol, 2021, 45(1):101470. https://doi.org/10.1016/j.clinre.2020.05.018 Search in Google Scholar

16 Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an update review. Arch Toxicol, 2015, 89:193-199. https://doi.org/10.1007/s00204-014-1432-2 Search in Google Scholar

17 Begriche K, Penhoat C, Bernabeu-Gentey P, et al. Acetaminophen-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease: a critical review. Livers, 2023, 3(1):33-53. https://doi.org/10.3390/livers3010003 Search in Google Scholar

18 McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res, 2013, 30:2174-2187. https://doi.org/10.1007/s11095-013-1007-6 Search in Google Scholar

19 Yoon E, Babar A, Choudhary M, et al. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol, 2016, 28:131-142. https://doi.org/10.14218/JCTH.2015.00052 Search in Google Scholar

20 Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev, 2012, 44:88-106. https://doi.org/10.3109/03602532.2011.602688 Search in Google Scholar

21 Meunier L, Larrey D. Recent advances in hepatotoxicity of non steroidal anti-inflammatory drugs. Annals of Hepatology, 2018, 17(2):187–191. https://doi.org/10.5604/01.3001.0010.8633 Search in Google Scholar

22 Simmons DL, Botting RM, Hla T. Ciclooxigenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev, 2004, 56(3):387-437. https://doi.org/10.1124/pr.56.3.3 Search in Google Scholar

23 Hoffmann C. COX-2 in brain and spinal cord implications for therapeutic use. Current medicinal chemistry, 2000, 7:1113-1120. https://doi.org/10.2174/0929867003374282 Search in Google Scholar

24 Bacchi S, Palumbo P, Sponta A, et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem, 2012, 11(1):52–64. https://doi.org/10.2174/187152312803476255 Search in Google Scholar

25 Lewis JH, Stine JG. Nonsteroidal antiinflammatory drugs and leukotriene receptor antagonists. In: Drug-induced liver disease. 3rd ed. N. Kaplowitz, D. L. DeLeve (Eds.). Paris, Elsevier, 2013, 369-401. Search in Google Scholar

26 O’Connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM, 2003, 96(11):787–791. https://doi.org/10.1093/qjmed/hcg138 Search in Google Scholar

27 Zoubek ME, Lucena MI, Andrade RJ, et al. Systematic review: ibuprofen-induced liver injury. Aliment Pharmacol Ther, 2020, 51(6):603-611. https://doi.org/10.1111/apt.15645 Search in Google Scholar

28 Schmeltzer PA, Kosinski AS, Kleiner DE, et al. Liver injury from nonsteroi dal anti-inflammatory drugs in the United States. Liver Int, 2016, 36:603-609. https://doi.org/10.1111/liv.13032 Search in Google Scholar

29 Nouri A, Heidarian E, Nikoukar M. Effects of N-acetyl cysteine on oxidative stress and TNF-Į gene expression in diclofenac-induced hepatotoxicity in rats. Toxicol Mech Methods, 2017, 27(8):561–567. https://doi.org/10.1080/15376516.2017.1334732 Search in Google Scholar

30 Kalra V. Reyes Syndrome. Apollo Medicine, 2008, 5(2):106–110. https://doi.org/10.1016/S0976-0016(11)60130-0 Search in Google Scholar

31 Sahu CR. Mechanisms involved in toxicity of liver caused by piroxicam in mice and protective effects of leaf extract of Hibiscus rosa-sinensis L. Clin Med Insights Arthritis Musculoskelet Disord, 2016, 9:9-13. https://doi.org/10.4137/CMAMD.S29463 Search in Google Scholar

32 Badawi MS. Histological study of the protective role of ginger on piroxicam-induced liver toxicity in mice. J Chin Med Assoc, 2019, 82(1):11-18. https://doi.org/10.1016/j.jcma.2018.06.006 Search in Google Scholar

33 Rainsford K. Anti-inflammatory drugs in the 21st century. Sub-cellular biochemistry, 2007, 42:3–27. https://doi.org/10.1007/1-4020-5688-5_1 Search in Google Scholar

34 Famularo G, Gasbarrone L, Minisola G. Probable celecoxib-induced hepatorenal syndrome. Ann Pharmacother, 2012, 46:610–611. https://doi.org/10.1345/aph.1Q671 Search in Google Scholar

35 Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf, 2010, 19:708–714. https://doi.org/10.1002/pds.1966 Search in Google Scholar

36 Pugh AJ, Barve AJ, Falkner K, et al. Drug-induced hepatotoxicity or drug-induced liver injury. Clin Liver Dis, 2009, 13(2):277-294. https://doi.org/10.1016/j.cld.2009.02.008 Search in Google Scholar

37 Appiah J, Prasad A, Shah V, et al. Amoxicillin-clavula-nate induced liver injury in a young female. Cureus, 2023, 15(1):e33445. https://doi.org/10.7759/cureus.33445 Search in Google Scholar

38 Polson JE. Hepatotoxicity due to antibiotics. Clin Liver Dis, 2007, 11(3):549-561. https://doi.org/10.1016/j.cld.2007.06.009 Search in Google Scholar

39 O’Donohue J, Oien KA, Donaldson P, et al. Co-amoxiclav jaundice: clinical and histological features and HLA class II associations. Gut, 2000, 47:717–720. https://doi.org/10.1136/gut.47.5.717 Search in Google Scholar

40 Fox JC, Szyjkowski RS, Sanderson SO, et al. Progressive cholestatic liver disease associated with clarithromycin treatment. The Journal of Clinical Pharmacology, 2002, 42(6):676-680. https://doi.org/10.1177/00970002042006011 Search in Google Scholar

41 Westphal JF, Brogard JM. Antibacterials and antifungal agents. In: Drug-induced liver disease. N. Kaplowitz, L. D. DeLeve (Eds.). New York, Marcel-Dekker, 2003, 471–504. Search in Google Scholar

42 Robles M, Toscano E, Cotta J, et al. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Curr Drug Saf, 2010, 5(3):212-222. https://doi.org/10.2174/157488610791698307 Search in Google Scholar

43 Löscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs, 2002, 16(10):669-694. https://doi.org/10.2165/00023210-200216100-00003 Search in Google Scholar

44 Smits JE, Wallenburg E, van Spanje A, et al. Valproate intoxication in a patient with blood valproate levels within therapeutic range. J Clin Psychiatry, 2017, 78(4):413-414. https://doi.org/10.4088/JCP.15cr10147 Search in Google Scholar

45 LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012. Search in Google Scholar

46 Patel AR, Nagalli S. Valproate Toxicity. Treasure Island (FL): Stat-Pearls [Updated 2021 Nov 25; cited 2022 March 4]. Available from: https://www.statpearls.com/ArticleLibrary/viewarticle/30391 Search in Google Scholar

47 Mahmoud AM, Hussein OE, Hozayen WG, et al. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARȖ and Nrf2: Protective effect of 18ȕ-Glycyrrhetinic acid. Chem Biol Interact, 2017, 270:59-72. https://doi.org/10.1016/j.cbi.2017.04.009 Search in Google Scholar

48 Abo-Haded HM, Elkablawy MA, Al-Johani Z, et al. Hepato-protective effect of sitagliptin against methotrexate induced liver toxicity. PLoS One, 2017, 12(3):e0174295. https://doi.org/10.1371/journal.pone.0174295 Search in Google Scholar

49 Ezhilarasan D. Hepatotoxic potentials of methotrexate: understanding the possible toxicological molecular mechanisms. Toxicology, 2021, 458:152840. https://doi.org/10.1016/j.tox.2021.152840 Search in Google Scholar

50 Santhakumar P, Roy A, Ganesh MK, et al. Ethanolic extract of Capparis decidua fruit ameliorates methotrexate-induced hepatotoxicity by suppressing oxidative stress and inflammation by modulating nuclear factor-kappa B signaling pathway. Pharmacogn Mag, 2021, 17:143-150. DOI:10.4103/pm.pm_402_20 Search in Google Scholar

51 Combrink M, du Preez I. Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin. Toxicology letters, 2020, 322:104-110. https://doi.org/10.1016/j.toxlet.2020.01.018 Search in Google Scholar

52 Metushi I, Uetrecht J, Phillips E. Mechanism of isoniazid-induced hepatotoxicity: then and now. Br J Clin Pharmacol, 2016, 81(6):1030-1036. doi:10.1111/bcp.12885 Search in Google Scholar

53 Jia ZL, Cen J, Wang JB, et al. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway. Chemosphere, 2019, 227:541-550. https://doi.org/10.1016/j.chemosphere.2019.04.026 Search in Google Scholar

54 Lei S, Gu R, Ma X. Clinical perspectives of isoniazid-induced liver injury. Liver Research, 2021, 5:45-52. https://doi.org/10.1016/j.livres.2021.02.001 Search in Google Scholar

55 Yang S, Hwang SJ, Park JY, et al. Association of genetic polymorphisms of CYP2E1, NAT2, GST, and SLCO1B1, with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ Open, 2019, 9(8):e027940. https://doi.org/10.1136/bmjopen-2018-027940 Search in Google Scholar

56 Santoso SB, Pribadi P, Irham LM. Isoniazid-induced liver injury risk level in different variants of N-acetyltransferase 2 (NAT2) polymorphisms: a literature review. Pharmacia, 2023, 70(4):973-981. https://doi.org/10.3897/pharmacia.70.e109869 Search in Google Scholar